IRIS
MOLINELLI, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.555
EU - Europa 3.415
AS - Asia 3.360
SA - Sud America 704
Continente sconosciuto - Info sul continente non disponibili 370
AF - Africa 245
OC - Oceania 8
Totale 16.657
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.299
SG - Singapore 1.052
IT - Italia 974
VN - Vietnam 774
CN - Cina 687
RU - Federazione Russa 625
BR - Brasile 556
HK - Hong Kong 334
FR - Francia 278
IE - Irlanda 264
SE - Svezia 246
DE - Germania 235
UA - Ucraina 177
GB - Regno Unito 170
FI - Finlandia 149
CA - Canada 124
IN - India 104
CI - Costa d'Avorio 100
BD - Bangladesh 84
NL - Olanda 67
TR - Turchia 58
ZA - Sudafrica 56
AR - Argentina 53
MX - Messico 49
DK - Danimarca 47
JP - Giappone 44
MA - Marocco 42
ES - Italia 36
IQ - Iraq 34
AT - Austria 32
PL - Polonia 29
EC - Ecuador 27
ID - Indonesia 26
KR - Corea 25
UZ - Uzbekistan 21
CR - Costa Rica 20
BE - Belgio 18
LT - Lituania 17
IL - Israele 16
VE - Venezuela 15
CL - Cile 14
CO - Colombia 14
PH - Filippine 14
PK - Pakistan 14
TH - Thailandia 12
PY - Paraguay 11
CZ - Repubblica Ceca 9
GT - Guatemala 9
JM - Giamaica 9
SA - Arabia Saudita 9
EG - Egitto 8
GR - Grecia 8
HN - Honduras 8
KE - Kenya 8
MY - Malesia 8
TN - Tunisia 8
AU - Australia 7
PE - Perù 7
SV - El Salvador 7
DZ - Algeria 6
NP - Nepal 6
SC - Seychelles 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
CW - ???statistics.table.value.countryCode.CW??? 5
NI - Nicaragua 5
TW - Taiwan 5
UY - Uruguay 5
PA - Panama 4
PS - Palestinian Territory 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EU - Europa 3
GP - Guadalupe 3
HR - Croazia 3
HU - Ungheria 3
JO - Giordania 3
KG - Kirghizistan 3
OM - Oman 3
PT - Portogallo 3
AL - Albania 2
BB - Barbados 2
GA - Gabon 2
GE - Georgia 2
KZ - Kazakistan 2
LY - Libia 2
PR - Porto Rico 2
QA - Qatar 2
SM - San Marino 2
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BY - Bielorussia 1
Totale 16.277
Salva come PNG Salva come JPEG
Città #
Ashburn 1.664
Singapore 666
Chandler 620
Dallas 504
San Jose 461
Council Bluffs 429
Hong Kong 323
Des Moines 315
Boardman 268
Ho Chi Minh City 259
Dublin 255
Fairfield 233
New York 217
Jacksonville 193
The Dalles 180
Hanoi 178
Los Angeles 168
Beijing 146
Seattle 121
Lauterbourg 114
Moscow 110
Wilmington 108
Houston 104
Abidjan 99
Woodbridge 93
Munich 92
Helsinki 89
Princeton 83
Lawrence 82
Rome 80
Milan 78
Cambridge 73
Santa Clara 68
Ann Arbor 62
Phoenix 62
San Mateo 62
Ancona 59
Buffalo 58
Centro 57
Chicago 56
São Paulo 56
Hefei 54
London 53
Da Nang 47
Orem 44
San Diego 42
Turin 42
Haiphong 39
Washington 39
Turku 38
Johannesburg 37
Brooklyn 35
Shanghai 35
Montreal 33
Pune 33
Tokyo 32
Boydton 29
Guangzhou 29
San Francisco 28
Denver 26
Warsaw 25
Wuhan 25
Nuremberg 24
Chennai 23
Columbus 23
Irvington 23
Naples 21
Toronto 21
Atlanta 20
Brussels 18
Amsterdam 17
Stockholm 17
Manchester 16
San José 16
Urbisaglia 16
Vienna 16
Frankfurt am Main 15
Hải Dương 15
Salt Lake City 15
Tashkent 15
Tolentino 15
Boston 14
Elk Grove Village 14
Marche 14
Miano 14
Baghdad 13
Rio de Janeiro 13
Biên Hòa 12
Clovis 12
Piscataway 12
Poplar 12
Curitiba 11
Mexico City 11
Philadelphia 11
Porto Alegre 11
Charlotte 10
Civitanova Marche 10
Kazan' 10
Mumbai 10
Perugia 10
Totale 10.280
Salva come PNG Salva come JPEG
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 343
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 253
Melanoma e tessuto adiposo peritumorale: studio preliminare sul ruolo delle adipocitochine nella caratterizzazione e prognosi di malattia 226
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 202
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. 196
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 193
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 189
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 176
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 174
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile 173
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 169
Oxidative stress and alterations of paraoxonases in atopic dermatitis 168
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 165
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 163
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 163
Involvement of the oral cavity in psoriasis: results of a clinical study 159
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 159
Bimekizumab: dual inhibition as a promising tool in the management of hidradenitis suppurativa 157
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 156
Biologic Therapy in Psoriasis: Safety Profile 155
MiR-146a-5p correlates with clinical efficacy in psoriasis patients treated with the TNF alpha inhibitor Adalimumab 155
Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts 154
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 154
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study 154
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 152
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art 151
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 151
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 149
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 149
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 147
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 147
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 146
Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review 144
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 144
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 143
Review: A safety profile of dalbavancin for onand off-label utilization 141
Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: A controlled retrospective clinical study 140
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 139
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 139
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 139
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma 139
Biological treatments for pediatric psoriasis: state of the art and future perspectives 138
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 138
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 138
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 137
Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study 136
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints 136
Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review 133
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 133
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 133
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 133
Relapsing acute generalized exanthematous pustolosis: a guess. 133
Kaposi-Juliusberg varicelliform eruption in patient suffering from Darier-White disease: a case report and review of the literature 133
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 133
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis 132
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 131
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 129
Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review 129
Topical application of fumaric acid esters improves appearance of nail psoriasis 129
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 129
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 128
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 128
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 128
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 128
Reticulated acanthoma with sebaceous differentiation 128
Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review 127
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 127
The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues 126
CT patterns of interstitial lung disease in patients with plaque psoriasis: a retrospective case series study 126
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 126
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 123
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 123
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 122
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 121
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 121
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 120
The sources of antimicrobial peptides against Gram-positives and Gramnegatives: our research experience 119
Mycosis Fungoides-like Eruption and Infliximab 119
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 118
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 118
Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues 117
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 116
Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations 115
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 115
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 115
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma 114
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 114
Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma 112
IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study 112
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 112
Bimekizumab in hidradenitis suppurativa: a valid and rapid emerging treatment 111
Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi 111
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 109
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 109
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 107
Oxidative Stress, High Density Lipoproteins and Hidradenitis Suppurativa: A Prospective Study 107
Role of daptomycin in cutaneous wound healing: a narrative review 105
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 105
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel 105
Sneddon-Wilkinson disease and monoclonal gammopathy of undetermined significance in the elderly: Case report 104
Totale 14.040
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022537 0 0 0 0 29 46 25 53 47 28 137 172
2022/20231.897 132 187 122 176 114 474 8 103 381 10 130 60
2023/20241.281 160 24 150 135 165 293 27 71 19 85 16 136
2024/20252.399 315 179 75 37 99 98 234 94 499 168 316 285
2025/20267.136 561 409 548 694 739 489 1.364 599 581 596 249 307
2026/20271.730 349 212 283 819 67 0 0 0 0 0 0 0
Totale 16.657